Skip to content

Evaluating efficacy of robot-assisted sclerotic therapy and bone grafting in treatment of subchondral cyst of hip and knee: a single-arm clinical trial

Evaluating efficacy of robot-assisted sclerotic therapy and bone grafting in treatment of subchondral cyst of hip and knee: a single-arm clinical trial

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2100053781
Enrollment
Unknown
Registered
2021-11-29
Start date
2022-01-01
Completion date
Unknown
Last updated
2022-10-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Osteoarthritis of hip and knee

Interventions

Experimental group:Dimensity surgical robot-assisted sclerotherapy injection for bone grafting

Sponsors

The Sixth People's Hospital Affiliated to Shanghai Jiaotong University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
40 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1. Aged 40 to 70 years; 2. The joint pain lasts for more than 6 months and the joint pain is most of the time in the last month; 3. X-ray shows Kellgren and Lawrence grade 2 or 3 osteoarthritis; 4. MRI shows that the maximum diameter of the subchondral cystic lesion of the joint is not less than 1cm and is accompanied by BML (greater than or equal to grade 1).

Exclusion criteria

Exclusion criteria: 1. Kellgren and Lawrence Level 1 or 4; 2. The affected knee has been injected with glucocorticoid or hyaluronic acid within the past 6 months; 3. The joint has undergone surgery or other operations are planned for the joint; 4. Suffering from other diseases such as: systemic or inflammatory joint disease (rheumatoid arthritis), a history of crystalline or neurological joints, other muscle, joint or nervous system diseases that affect the function of the lower limbs; 5. There is immunosuppression or acute infection; 6. Suffering from or had suffered from malignant tumor; 7. Have any other medical conditions that cannot participate in the study, including contraindications to MRI, such as pacemakers; 8. Pregnancy; 9. Body mass index (BMI) > 40 kg/m^2; 10. Inability to understand written and spoken Chinese; 11. History of any mental and psychological illness.

Design outcomes

Primary

MeasureTime frame
24-month body mass index level;

Countries

China

Contacts

Public ContactZhu Hongyi

The Sixth People's Hospital Affiliated to Shanghai Jiaotong University

420308955@qq.com+86 18930170316

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026